Watch Ticker

Onconetix, Inc. Common Stock

Go to Onconetix, Inc. Common Stock Website

$3.16

-0.01 (-0.32%)

Live

Previous Close

$3.17

Day Range

$0 - $0

Previous Day Range

$3.1601 - $3.415

Market Cap

$1.8 million USD

Day Vol.

Previous Day Vol.

273913

Currency

USD

Primary Exchange

None

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treat...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Globe Newswire - Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement

Onconetix and Ocuvex Therapeutics have signed a definitive merger agreement where Onconetix will acquire Ocuvex, with Ocuvex shareholders receiving 90% of the combined company's equity. The transaction is expected to close in Q4 and aims to bring ophthalmic therapeutic assets to the public markets.

Related tickers: ONCO.

Read Full Article

Avi Kapoor - Why Tellurian Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket - Benzinga

Tellurian Inc. shares rose sharply after Woodside Energy announced plans to acquire the company for $900 million. Several other stocks also saw significant pre-market movement, both positive and negative.

Related tickers: TELL, TELZ, NCPL, NCPLW, SERV, RR, CISO, VEEE, OFG, PRTG, RYAAY, SDIG, ONCO, NVOS, SGD, VIRI, SLRX, NKGN, NKGNW.

Read Full Article

Trending Tickers

Please sign in to view